Anti-caries composition containing taxifolin as well as preparation method and application of anti-caries composition

By combining taurine and sodium fluoride organically, the problems of high fluoride concentration and uneven antibacterial and anti-demineralization capabilities in existing anti-caries compositions are solved, achieving efficient and safe caries prevention and control, and suitable for oral care products such as toothpaste and mouthwash.

CN121818703APending Publication Date: 2026-04-10SICHUAN UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202610191863.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-02-10
Publication Date
2026-04-10

AI Technical Summary

Technical Problem

Existing caries prevention compositions often have high fluoride concentrations or an imbalance between antibacterial and demineralization resistance, posing toxicity risks and safety hazards, and failing to meet the clinical needs for highly effective antibacterial and demineralization resistance.

Method used

Taxodiacetic acid and sodium fluoride were combined at a ratio of 1 mg/mL: 700 ppm. Through their synergistic effect, they significantly inhibited the growth of Streptococcus mutans and biofilm formation, while enhancing the anti-demineralization effect. This mixture was then used to prepare oral care products such as toothpaste and mouthwash.

Benefits of technology

It significantly inhibits the growth of Streptococcus mutans and biofilm formation, reduces enamel lesions, slows down demineralization, has high biocompatibility, no obvious toxic side effects, and is more effective than single-component products. It is suitable for oral care products such as toothpaste and mouthwash.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121818703A_ABST
    Figure CN121818703A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of pharmaceutical compositions, and discloses an anti-caries composition containing taxifolin as well as a preparation method and application of the anti-caries composition containing taxifolin, the anti-caries composition containing taxifolin comprises taxifolin and sodium fluoride, and the concentration ratio of taxifolin to sodium fluoride is 1mg / mL: 700ppm. Under the concentration, taxifolin and sodium fluoride generate a mutual promotion synergistic effect, and sodium fluoride obviously enhances the bacteriostatic action of taxifolin, obviously prolongs the growth delay phase of streptococcus mutans and reduces the viable count peak value in the logarithmic phase; the inhibition rate on biofilm formation is 57.4 + / -2.1%, and the antibacterial effect is remarkably enhanced; meanwhile, taxifolin enhances the demineralization resistance of sodium fluoride, and the demineralization resistance effect of only 700ppm of sodium fluoride is obviously superior to that of 1000ppm of sodium fluoride. The method disclosed by the invention has more excellent bacteriostatic activity, higher demineralization resistance and higher biological safety, and has great popularization and application values.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pharmaceutical composition technology, specifically to an anti-caries composition containing taurine, its preparation method, and its application. Background Technology

[0002] The statements in this section provide only background information relevant to the disclosure of this application and may not constitute prior art.

[0003] Dental caries is a prevalent chronic oral infectious disease worldwide. Its core mechanism involves the disruption of the dynamic balance between demineralization and remineralization of the hard dental tissues (enamel, dentin, and cementum) under the combined influence of multiple factors, primarily bacteria (including host susceptibility, dietary habits, and time). This ultimately leads to chronic destruction of the hard tissues, clinically manifesting as chalky white spots, discoloration, and cavities on the tooth surface. In severe cases, it can cause pulpitis, periapical lesions, and even affect overall health, making it one of the non-communicable diseases of particular concern to the World Health Organization. Epidemiological surveys show that nearly 2.3 billion people worldwide have untreated caries. Even with the continued implementation of traditional caries prevention measures (such as fluoride application, fissure sealants, and mechanical plaque control), overall caries control still faces significant challenges. Developing new, efficient, and safe caries prevention strategies has become an important topic in the field of oral medicine.

[0004] Streptococcus mutans (S. mutans) is a recognized core cariogenic bacterium, and its cariogenic ability depends on the synergistic effect of a series of virulence factors: First, Streptococcus mutans initially colonizes the enamel surface through non-sucrose-dependent adhesion (such as mediated by the surface protein SpaP). Subsequently, in the presence of sucrose, it synthesizes extracellular polysaccharides (EPS) through glycosyltransferases (GtfB, GtfC, GtfD). GtfB mainly produces water-insoluble glucans, GtfC synthesizes both water-soluble and water-insoluble glucans, and GtfD mainly synthesizes water-soluble glucans. These EPS constitute the core matrix of the biofilm, which not only enhances the aggregation ability between bacteria but also encapsulates bacteria to form a "protective barrier" and reduces the penetration of external antimicrobial substances. Second, Streptococcus mutans can metabolize dietary carbohydrates (especially sucrose) to produce a large amount of organic acids (such as lactic acid), causing the local pH of the biofilm to drop to 5.0. Below the critical pH for enamel demineralization, hydroxyapatite in enamel dissolves, triggering demineralization. Furthermore, *Streptococcus mutans* mediates the anchoring of surface proteins (such as SpaP and GbpB) to the cell wall via sorting enzyme A (SrtA), further enhancing bacterial adhesion and biofilm stability. Meanwhile, the glucan-binding protein GbpB, by mediating the interaction between bacteria and glucan, becomes a key factor in sucrose-dependent adhesion. Therefore, inhibiting the growth, adhesion, acid production, and biofilm formation of *Streptococcus mutans* is the core target for blocking the development and progression of dental caries.

[0005] Among the current clinical and daily applications of caries prevention methods, fluoride (such as sodium fluoride, NaF) is the most widely used anti-mineralization and remineralization agent. It binds with dental enamel hydroxyapatite to form more acid-resistant fluorapatite, and at the same time serves as a calcium and fluoride ion storage to promote remineralization. The conventional application concentration (such as 1000 ppm NaF) shows certain caries prevention effect in in vitro and in vivo experiments. However, the application of fluoride has obvious limitations: on the one hand, long-term excessive intake of fluoride may cause toxicity reactions such as dental fluorosis and fluorosis, especially in sensitive groups such as children and infants; on the other hand, single fluoride has weak direct inhibitory effect on Streptococcus mutans biofilm, and it is difficult to effectively destroy the structure of mature biofilm, and long-term use may induce the production of fluoride-resistant strains, weakening the caries prevention effect.

[0006] Natural products have become a hot spot for the development of new caries prevention agents due to their wide sources, high biological safety, and low risk of drug resistance. Taxifolin (TAX, also known as dihydroquercetin) is a kind of dihydroflavonoids extracted from natural materials such as larch, grape, and olive. It has been identified by the National Health Commission as a "new food material" in 2021, and has multiple biological activities such as antibacterial, antioxidant, and anti-inflammatory. However, the antibacterial activity of taxifolin alone is still weaker than that of traditional broad-spectrum antibacterial agents, and the anti-mineralization effect is better than that of the blank control, but still needs to be improved compared with high-concentration fluoride (1000 ppm NaF), which is difficult to meet the clinical demand for "high-efficiency antibacterial + strong anti-mineralization" integrated caries prevention.

[0007] Chinese invention patent application 202510665850.1 discloses an anti-caries toothpaste containing sugarcane leaf polysaccharide, which is made of sugarcane leaf polysaccharide, propolis extract, antibacterial peptide, green tea extract, auxiliary agent, deionized water and natural tea tree oil. Its antibacterial effect is obvious, but the ability to resist tooth tissue demineralization has not been evaluated. Chinese invention patent 202510074006.1 discloses an anti-cavity mouthwash, which is composed of the following percentage components: 0.1-0.5% sodium fluoride, 0.1-0.5% monofluorophosphate sodium, 0.1-0.5% olaflur, 0.5-1% hydroxyapatite, 0.5-1% lactobacillus, 0.5-1.5% green tea extract, 0.5-1.5% honeysuckle extract, 1.5-2% menthol, 0.5-1% sodium citrate, 2-3% honey, 1.5-3% licorice extract, 0.5-1.5% lemon extract, 0.5-1.5% ascorbic acid, 2-3% polyoxyethylene hydrogenated eucalyptus oil and water. A large dose of fluoride-containing substances is added, and high-dose fluoride-containing substances have the risk of causing side effects such as fluoride poisoning during long-term use. Moreover, menthol, lemon extract (containing citric acid) and ascorbic acid (vitamin C, acidic) are all acidic or irritating components, and long-term use may cause dryness and tingling of the oral mucosa. Therefore, the mouthwash still has certain safety risks.

[0008] In summary, the existing anti-caries compositions have the problems of high fluoride concentration or unbalanced antibacterial and anti-demineralization ability, and there is an urgent need to develop new drug compositions with integrated anti-caries function. SUMMARY

[0009] The present application aims to solve the problems of high fluoride concentration or unbalanced antibacterial and anti-demineralization ability in the existing anti-caries compositions, and provides an anti-caries composition containing taxifolin and its preparation method and application. Through the organic combination of taxifolin and sodium fluoride, excellent synergistic antibacterial and anti-enamel demineralization effects are achieved, and the overall biological safety is high without obvious toxic side effects, which can safely and effectively prevent and control the occurrence and development of dental caries.

[0010] The technical solution of the present application is as follows: An anti-caries composition containing taxifolin, comprising taxifolin (TAX) and sodium fluoride (NaF), wherein the concentration ratio of taxifolin to sodium fluoride is 1 mg / mL:700 ppm.

[0011] Based on experimental verification, the inhibition rate of Streptococcus mutans biofilm under this concentration combination is 57.4±2.1%, which is significantly better than that of single 1 mg / mL taxifolin or 1000 ppm sodium fluoride, and the anti-demineralization effect is equivalent to that of 1000 ppm sodium fluoride; and a synergistic and mutually enhancing effect is produced.

[0012] Preferably, the purity of said taxifolin is ≥98% by mass percentage, avoiding impurities to irritate the oral mucosa.

[0013] Preferably, the effective component content of said sodium fluoride is ≥99.5% by mass percentage, analytical pure grade, meeting the purity requirement of fluoride raw material in oral care products, and stably playing the anti-decalcification role, avoiding impurities to affect the composite effect.

[0014] Preferably, said taxifolin is a product purified from natural raw materials such as larch and grape, and said sodium fluoride is an analytical pure reagent.

[0015] Another aspect of the present application provides a preparation method of a caries-preventing composition containing taxifolin as described above, comprising the following steps: Mother liquor preparation: dissolve taxifolin (TAX) with 10% dimethyl sulfoxide (DMSO) aqueous solution to prepare a taxifolin mother liquor of 20 mg / mL; dissolve sodium fluoride (NaF) with double-distilled water to prepare a sodium fluoride mother liquor of 7000 ppm.

[0016] Mother liquor mixing and dilution: take 0.5 mL of taxifolin mother liquor + 1 mL of sodium fluoride mother liquor, add a dilution base to make the total volume of the mixed solution 10 mL, and the final taxifolin concentration is 1 mg / mL and the final sodium fluoride concentration is 700 ppm.

[0017] Preferably, the dilution base is double-distilled water, BHI medium or other formulation bases possibly added in oral care products.

[0018] Another aspect of the present application provides an application of the caries-preventing composition containing taxifolin as described above in preparing a medicine or oral care product for inhibiting oral bacteria.

[0019] Preferably, the oral care product includes toothpaste, mouthwash, oral gel and the like.

[0020] Preferably, the oral bacteria include Streptococcus mutans (S. mutans, a core cariogenic bacterium in oral cavity), and the composition can prevent and assist in treating caries caused by Streptococcus mutans.

[0021] Another aspect of the present application provides a caries-preventing toothpaste containing taxifolin and sodium fluoride, and the concentration ratio of said taxifolin and sodium fluoride is 1 mg / mL:700 ppm.

[0022] According to a preferred embodiment, the caries-preventing toothpaste further contains an abrasive, a humectant, a surfactant and a thickening agent.

[0023] Compared with the prior art, the present application has the following beneficial effects: 1. A caries-preventing composition containing taxifolin, which can significantly inhibit the growth of Streptococcus mutans (prolong the lag phase of bacterial growth, reduce the number of viable bacteria), biofilm formation (inhibition rate 57.4±2.1%), while reducing the depth of enamel lesions and mineral loss, and delaying the demineralization process; based on the optimized ratio of taxifolin and sodium fluoride, they work synergistically with each other, while enhancing the antibacterial effect of taxifolin and the resistance mineralization effect of sodium fluoride, the effect is significantly better than that of high-concentration single component; unexpected technical effects are produced. 2. The use of a caries-preventing composition containing taxifolin, the composition in the technical solution can be added to various oral products (such as toothpaste, mouthwash, oral gel, etc.), which has a significant inhibitory effect on the growth, proliferation and biofilm formation of oral pathogenic bacteria Streptococcus mutans, and can effectively prevent caries caused by Streptococcus mutans, and has a wide range of application scenarios. 3. A preparation method of a caries-preventing composition containing taxifolin, taxifolin is a "new food material", and sodium fluoride is a safe caries-preventing component with a lower dose than the clinically commonly used dose, and the two have high biological safety and no obvious toxic and side effects after compounding; and the preparation process is simple, only needs to dilute and mix the mother liquor, is easy to industrialize, and has extremely high clinical conversion value. BRIEF DESCRIPTION OF DRAWINGS

[0024] Figure 1 is a graph of the effect of Examples 1-3 and Comparative Examples 1-3 on the growth curve of Streptococcus mutans; Figure 2 is a graph of the effect of Examples 1-3 and Comparative Examples 1-3 on the number of viable Streptococcus mutans; Figure 3 is a graph of the effect of Examples 1-3 and Comparative Examples 1-3 on the biofilm formation of Streptococcus mutans; Figure 4 is a graph of the effect of Examples 1 and Comparative Examples 1-3 on the number of viable Streptococcus mutans in an in vitro tooth model; Figure 5 is a graph of the effect of Examples 1 and Comparative Examples 1-3 on the lesion depth in an in vitro tooth model under a polarized light microscope; Figure 6 is a graph of the effect of Examples 1 and Comparative Examples 1-3 on the hardness loss rate of an in vitro tooth model. DETAILED DESCRIPTION

[0025] The specific examples listed in the present application are only as examples of the present application, and the present application is not limited to the specific examples described below. Any equivalent modifications and alternatives to the examples described below are also within the scope of the present application for those skilled in the art. Therefore, equivalent transformations and modifications made without departing from the spirit and scope of the present application should be encompassed within the scope of the present application. The specific conditions not specified in the examples are carried out according to the conventional conditions or the conditions recommended by the manufacturer. All reagents or instruments not specified by the manufacturer are conventional products that can be purchased on the market. In order to better illustrate the present application, numerous specific details are given in the following specific embodiments. Those skilled in the art should understand that the present application can also be implemented without certain specific details. In some embodiments, methods, means, apparatus and steps that are well known to those skilled in the art are not described in detail in order to highlight the main idea of the present application.

[0026] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Unless otherwise indicated, all measurements used in the description herein are made at standard conditions using standard techniques. Unless otherwise stated, the units used in the specification are international standard units, and the numerical values and numerical ranges appearing in the present application should be understood to include the systematic errors that are inevitable in industrial production.

[0027] 1. Raw materials: Taxifolin (TAX): purity ≥98%, purchased from Shanghai Yuan Ye Biological Technology Co., Ltd.; Sodium fluoride (NaF): analytical pure, purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.; Streptococcus mutans (S. mutans UA159): purchased from China Oral Microbial Resource Database (National Key Laboratory for Prevention and Treatment of Oral Diseases); Brain heart infusion broth (BHI) medium: BR grade, purchased from Oxoid Company, UK; Sucrose-containing brain heart infusion broth (BHIS): 1% sucrose (purchased from Beijing Solaybao Technology Co., Ltd.) was added to the BHI medium; 2. Instruments Molecular Devices (USA), Vickers microhardness tester (Matsuzawa, Japan), polarized light microscope (NIKON, Japan), EXAKT hard tissue microtome (EXAKT300; EXAKT, Nordstedt, Germany); Reagent consumables: dimethyl sulfoxide (DMSO) (Solebao, Beijing, China), phosphate buffered saline solution (Solebao, Beijing, China), agar (Boaotuda, Beijing, China), glacial acetic acid (Jinshan, Chengdu, China), crystal violet (Solebao, Beijing, China), glutaraldehyde (Kelun, Chengdu, China), anhydrous ethanol (Kelun, Chengdu, China), 96-well plate, 48-well plate, 24-well plate, 12-well plate, 6-well plate (Corning, USA), sterile 100mm culture dish (Corning, USA), thymol solution (Macklin, Shanghai, China), artificial saliva (Yuan Ye Biotechnology, Shanghai, China), polymethyl methacrylate (Macklin, Shanghai, China), sealing film (amcor, USA), chlorhexidine CHX (Yuan Ye Biotechnology, Shanghai, China).

[0028] The features and performances of the present application are further described in detail below in combination with examples.

[0029] Example 1: A caries-preventive composition containing taxifolin and its preparation The complex composition contains, by final concentration: 1mg / mL taxifolin (TAX) + 700ppm sodium fluoride (NaF).

[0030] Preparation method: Preparation of mother liquor: dissolve taxifolin powder with 10% dimethyl sulfoxide (DMSO, Solebao) aqueous solution into a 20mg / mL mother liquor, dissolve sodium fluoride with double distilled water (DDW) into a 7000ppm mother liquor; Mixing and dilution of mother liquor: when used, dilute the mother liquor with BHI medium to make the final concentration of taxifolin 1mg / mL, the final concentration of sodium fluoride 700ppm, and the final concentration of DMSO ≤0.5%.

[0031] Example 2: A caries-preventive composition containing taxifolin and its preparation The complex composition contains, by final concentration: 1mg / mL taxifolin (TAX) + 600ppm sodium fluoride (NaF).

[0032] Preparation method: Preparation of mother liquor: dissolve taxifolin powder with 10% dimethyl sulfoxide (DMSO, Solebao) aqueous solution into a 20mg / mL mother liquor, dissolve sodium fluoride with double distilled water (DDW) into a 7000ppm mother liquor; Mixing and dilution of mother liquor: when used, dilute the mother liquor with BHI medium to make the final concentration of taxifolin 1mg / mL, the final concentration of sodium fluoride 600ppm, and the final concentration of DMSO ≤0.5%.

[0033] Example 3: A caries-preventive composition containing taxifolin and its preparation The complex composition comprises 1 mg / mL taxifolin (TAX) + 800 ppm sodium fluoride (NaF) by final concentration.

[0034] Preparation method: Mother liquor preparation: dissolve taxifolin powder into 20 mg / mL mother liquor with 10% dimethyl sulfoxide (DMSO, Solabia) aqueous solution, and dissolve sodium fluoride into 7000 ppm mother liquor with double distilled water (DDW); Mother liquor mixing and dilution: when used, dilute the mother liquor with BHI medium to make the final concentration of taxifolin 1 mg / mL, the final concentration of sodium fluoride 800 ppm, and the final concentration of DMSO ≤0.5%.

[0035] Comparative Example 1 Final concentration: 1 mg / mL taxifolin, diluted with 10% DMSO, final concentration of DMSO ≤0.5% (TAX group).

[0036] Comparative Example 2 Final concentration: 1000 ppm sodium fluoride, diluted with DDW, as a positive control group (NaF group).

[0037] Comparative Example 3 Double distilled water (DDW) + 0.5% DMSO, as a negative control group.

[0038] Test Example 1: Antibacterial activity and biofilm formation inhibition test of the complex composition on Streptococcus mutans 1.1 Preparation of culture medium Preparation of liquid culture medium: weigh 37 g of brain heart infusion broth (BHI) culture medium in a beaker, dissolve with distilled water, and make up to 1 L, then divide into appropriate conical flasks and seal with a sealing film; sterilize at 120°C for 20 min and prepare for use.

[0039] Preparation of solid culture medium: weigh 37 g of brain heart infusion broth (BHI) culture medium and 15 g of agar in a beaker, add an appropriate amount of distilled water to dissolve, stir evenly, adjust the pH value, then divide into appropriate size conical flasks and seal with a sealing film; sterilize at 120°C for 20 min, then divide into sterile culture dishes (this operation is carried out on a clean bench) when the temperature drops below 50°C, and cool for use.

[0040] 1.2 Preparation of bacterial suspension Streptococcus mutans bacterial suspension was streaked in solid culture medium for 24 h. Then, a single colony with good growth was selected and inoculated into liquid culture medium. The culture was carried out under anaerobic conditions (37℃, 80% N2, 10% H2 and 10% CO2) until the logarithmic growth phase. The absorbance value (OD600nm) at a wavelength of 600nm was measured by microplate reader. The absorbance value OD600nm was adjusted to 0.5 and diluted 100 times for subsequent experiments.

[0041] 1.3 Growth Curve Measurement Add 100 μL of sample (Examples 1-3, Comparative Examples 1-3, final concentration as set in Examples / Comparative Examples) + 100 μL of bacterial suspension to each well of a 96-well plate; ELISA reader continuously monitored for 24 hours under anaerobic conditions at 37℃, measuring OD every 1 hour. 600 Values ​​are used to plot growth curves.

[0042] 1.4 Biofilm viable cell count (CFU count) Streptococcus mutans suspension was streaked in solid medium for 24 hours. Then, vigorous single colonies were selected and inoculated into liquid medium. After a biofilm of Streptococcus mutans formed, the supernatant was discarded, and the cells were washed three times with phosphate-buffered saline (PBS) to remove airborne bacteria. 1 mL of PBS was added to each well, and the biofilm at the bottom of the well was scraped off with a pipette tip, resuspended, and transferred to sterile EP tubes. The suspension was then sonicated to mix. Each bacterial suspension was then diluted (1:10) sequentially and evenly spread onto BHI agar plates. After anaerobic incubation at 37 °C for 24 hours, suitable agar plates (30-300 colonies) were selected for colony-forming units (CFU) counting.

[0043] 1.5 Determination of biofilm formation (crystal violet staining method) The amount of *Streptococcus mutans* biofilm formed was determined using crystal violet staining. *Streptococcus mutans* bacterial culture was streaked in solid medium for 24 h. Then, healthy single colonies were inoculated into liquid medium. After biofilm formation, the biofilm was gently rinsed three times with PBS overnight to remove unformed bacteria and air-dried at room temperature. The biofilm was fixed with 2.5% glutaraldehyde for 15–30 min. After gently rinsing three times with PBS and air-drying at room temperature, the biofilm was stained with 0.1% crystal violet solution for 15–30 min, rinsed with distilled water to remove excess crystal violet stain, and air-dried at room temperature. Glacial acetic acid (33%) was added to destain the stained cells for 30 min. The eluent from each well was collected into a new plate, and the absorbance at OD600 nm was measured using a microplate reader.

[0044] Experimental results: 1. Growth curve like Figure 1The graphs showing the effects of Examples 1-3 and Comparative Examples 1-3 on the growth curves of Streptococcus mutans are presented. As can be seen from the graphs, the lag phase of Streptococcus mutans in Example 1 group was prolonged to 8 hours (compared to 2 hours in the TAX group of Comparative Example 1 and 2 hours in the NaF group of Comparative Example 2), and the logarithmic OD... 600 The peak value was 0.203±0.005 (0.387±0.007 for Comparative Example 1, 0.416±0.014 for Comparative Example 2, and close to 0.500 for Comparative Example 3). The number of viable bacteria during the plateau phase was significantly lower than that of other groups, indicating that the composite composition of Example 1 of this application has a more lasting inhibitory effect on bacterial proliferation.

[0045] As can be seen from the figure, when the NaF concentration was 600 ppm in Example 2 and 800 ppm in Example 3, the bacterial growth lag phase was shortened, and the bacteria rapidly entered the logarithmic growth phase. However, the OD during the logarithmic phase in Examples 2 and 3 was significantly lower. 600 The peak values ​​were all lower than those of comparative examples 1-3; while the antibacterial effect of NaF at a concentration of 700 ppm in Example 1 was significantly better than that of Examples 2 and 3. This indicates that the antibacterial synergistic effect of the two was significant when the NaF concentration was 700 ppm in Example 1 of this application.

[0046] 2. Biofilm viable cell count (CFU count) like Figure 2 As shown, the number of viable bacteria in the biofilm of Example 1 group was 6.03±0.02 log CFU / mL, which was significantly lower than that of Comparative Example 3 (8.38±0.21 log CFU / mL), Comparative Example 1 (7.00±0.09 log CFU / mL), Example 2 (6.96±0.05 log CFU / mL), Example 3 (6.57±0.12 log CFU / mL), and Comparative Example 2 (7.51±0.08 log CFU / mL) (p<0.05). This confirms that 1 mg / mL of taxanein (TAX) combined with 700 ppm sodium fluoride (NaF) has the best killing effect on Streptococcus mutans in biofilm.

[0047] 3. Determination of biofilm formation (crystal violet staining method) like Figure 3 As shown, the biofilm inhibition rate of the Example 1 group was 57.4±2.1%, which was significantly higher than that of the Comparative Example 1 group (25.1±3.2%) and the Comparative Example 2 group (29.6±2.3%) (p<0.05), indicating that the composition of 1 mg / mL Taxodiacetic acid (TAX) combined with 700 ppm sodium fluoride (NaF) had the strongest inhibitory effect on the formation of biofilm of Streptococcus mutans.

[0048] Test Example 2: Effect of the composite composition on inhibiting in vitro demineralization of Streptococcus mutans 2.1 Tooth enamel sample preparation Human third molars with intact crowns were collected (approved by the Ethics Committee of West China Hospital, batch number WCHSIRB-D-2025-539) and stored in 0.4% thymol solution; Teeth with fluorosis, cracks, enamel or dentin defects, and restorations were excluded. The crowns were cut into small pieces of uniform size with a low-speed cutter and embedded in polymethyl methacrylate overnight for hardening. The samples were polished with 800-mesh, 1000-mesh, and 1200-mesh sandpaper to form a 4x4mm 2 windowed surface on the enamel surface. Then the hardness value of the windowed surface was measured with a microhardness tester. Samples with hardness values ranging from 300 to 410 VHN were selected for subsequent experiments. Caries-causing biofilms were cultured on the enamel blocks. The enamel blocks were placed in a 24-well plate. 1.5 mL of S. mutans bacterial suspension (prepared in the preparation step of 1.2 bacterial suspension in Test Example 1) was added, and after 24 hours of anaerobic culture at 37°C, a biofilm was formed on the windowed surface of the enamel block.

[0049] 2.2 Demineralization cycle model construction The enamel blocks were randomly divided into 4 groups (Example 1, Comparative Examples 1-3), with 3 samples in each group; Demineralization cycle process: the samples were soaked in the treatment solution for 5 minutes, and then soaked in modified artificial saliva for 12 hours, for a total of 4 days of cycling; The treatment solution and artificial saliva were changed daily, and each treatment was preceded by 3 PBS rinses.

[0050] 2.3 CFU counting of biofilm After 4 days of cycle treatment, the biofilm on the sample was collected and resuspended in sterile PBS. The bacterial suspension was gradient-diluted and inoculated on BHI agar plates. After 24 hours of anaerobic culture at 37°C, CFU counting was performed. The viable cell rate = experimental group / control group x 100%.

[0051] 2.4 Polarized light microscopy (PLM) observation After washing and drying the enamel samples on which the biofilm was collected in Section 2.3, the samples were cut into 600µm-thick sections perpendicular to the windowed surface using a hard tissue sectioning machine with a diamond-coated saw blade, then the sections were thinned to 90-120µm using 1500-mesh sandpaper, and the section thickness was measured using a digital micrometer. The sections were placed on a glass slide and a suitable amount of double-distilled water was added to immerse the sections, and then observed under a polarized light microscope.

[0052] 2.5 Surface microhardness (SMH) measurement The surface hardness of the enamel blocks was measured by a microhardness tester, and the hardness loss rate (SMHR%) was calculated (SMHR%=(SMH0-SMH1) / SMH0x100%, SMH0 is the hardness before demineralization, and SMH1 is the hardness after demineralization).

[0053] Statistical processing SPSS software was used for statistical analysis. The normality of data was tested by Shapiro-Wilk test, and the homogeneity of variance was tested by Levene's test. The results were analyzed by one-way analysis of variance, and then SNK method was used for multiple comparisons. The significance level was set as α=0.05. Then the data were plotted by Graphpad Prism 10 software.

[0054] Experimental results: As Figure 4 shown, no viable bacteria were detected in the Example 1 group (Mix). Compared with the negative control group, the viable bacteria count in the experimental groups treated with TAX and NaF was significantly reduced, but the effect was not as good as that of the Example 1 group. This result is consistent with the phenotypic results of Test Example 1.

[0055] As Figure 5 shown, the tooth of the Comparative Example 1-3 group had a visible deep lesion area, and the lesion area of the Example 1 group was shallower than that of the other groups, indicating that it had a stronger inhibitory effect on demineralization.

[0056] As Figure 6 shown, the SMHR% of the Example 1 group was 4.69±1.25%, which was significantly lower than that of the Comparative Example 1 (22.85±6.60%) (p<0.05 ), the Comparative Example 2 (17.05±5.21%) and the Comparative Example 3 (52.94±3.11%), further verifying its excellent anti-demineralization potential.

[0057] The core innovation of the present application is that 1mg / mL taxifolin is compounded with 700ppm sodium fluoride for the first time, and through the synergistic effect of the two (bacteriostatic effect of taxifolin and resistance to tooth tissue demineralization of sodium fluoride), the dual anti-caries effect of "high antibacterial activity + high anti-demineralization" is achieved. The experimental results show that the antibacterial activity of the composite composition is better than that of single taxifolin or 1000ppm sodium fluoride, and the anti-demineralization effect is better than that of 1000ppm sodium fluoride and single taxifolin, and it also has good biological safety (taxifolin is a "new food raw material", and sodium fluoride is lower than the clinically commonly used dose), which can be widely used in toothpaste, mouthwash and other oral care products, and provides a new and efficient solution for the prevention and treatment of dental caries.

[0058] The above embodiments only express the specific implementation of the present application, which is described in more detail and specifically, but cannot be understood as a limitation to the protection scope of the present application. It should be noted that for those skilled in the art, without departing from the technical concept of the present application, a number of modifications and improvements can be made, which are all within the protection scope of the present application.

Claims

1. An anti-caries composition comprising taxifolin, characterized in that, The taxifolin is in a concentration ratio of 1 mg / mL: 700 ppm with the sodium fluoride.

2. The anti-caries taxifolin-containing composition according to claim 1, characterized in that, The purity of the taxifolin is ≥98% by mass percentage.

3. The anti-caries taxifolin-containing composition according to claim 1, characterized in that, The effective component content of the sodium fluoride is ≥99.5% by mass percentage, which is an analytical purity grade and meets the purity requirement of fluoride raw materials in oral care products.

4. The anti-caries taxifolin-containing composition according to claim 1, wherein the taxifolin is in an amount of 0.0001 to 0.1% by weight. The taxifolin is a product extracted and purified from natural materials of larch and grape.

5. A method of preparing a caries-preventive composition comprising taxifolin according to any one of claims 1 to 4, characterized in that, The method comprises the following steps: Mother liquor preparation: dissolve taxifolin in 10% dimethyl sulfoxide aqueous solution to prepare taxifolin mother liquor; dissolve sodium fluoride in double distilled water to prepare sodium fluoride mother liquor; Mother liquor mixing and dilution: take the taxifolin mother liquor and the sodium fluoride mother liquor, and dilute them so that the final concentration of taxifolin is 1 mg / mL and the final concentration of sodium fluoride is 700 ppm.

6. Use of the anti-caries composition containing taxifolin according to any one of claims 1-4 in the preparation of a medicine or oral care product for inhibiting oral bacteria.

7. Use according to claim 6, characterized in that, The oral care product comprises toothpaste, mouthwash or oral gel.

8. Use according to claim 6, characterized in that, The oral bacteria comprise Streptococcus mutans.

9. A caries-preventive toothpaste, characterized by comprising: The taxifolin is in a concentration ratio of 1 mg / mL: 700 ppm with the sodium fluoride.

10. The anticaries toothpaste according to claim 9, wherein The anti-caries composition further comprises abrasives, humectants, surfactants and thickening agents. The taxifolin is in a concentration ratio of 1 mg / mL: 700 ppm with the sodium fluoride. The anti-caries composition further comprises abrasives, humectants, surfactants and thickening agents.

Citation Information

Patent Citations

  • A kind of mouthwash with effective anti-moth function and preparation method thereof

    CN119770355A

  • Anti-decayed tooth toothpaste containing sugarcane leaf polysaccharide and preparation method of anti-decayed tooth toothpaste

    CN120392627A